| |
| |
|
| Insider
Information: |
Belsky Marc |
| Relationship: |
CFO |
| City: |
South San Francisco |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
28,698 |
|
|
Indirect Shares
|
46,158 |
|
|
| Direct
Value |
$518,465 |
|
|
|
Indirect Value
|
$1,679,633 |
|
|
| Total
Shares |
74,856 |
|
|
| Total
Value |
$2,198,099 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
0
|
|
Stock
price went up :
|
1
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
1.0
|
0.0
|
| Percentage
Gain/Loss : |
 85.2%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Five Prime Therapeutics Inc |
FPRX |
Senior Vice President ... |
2018-02-05 |
13,314 |
2018-02-05 |
44,158 |
Premium* |
|
|
Kezar Life Sciences, Inc. |
KZR |
CFO |
2020-02-04 |
15,384 |
2020-02-04 |
2,000 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
23 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| KZR |
Kezar Life Sciences, Inc. |
CFO |
• – – |
2020-02-04 |
4 |
B |
$2.60 |
$39,998 |
D/D |
15,384 |
15,384 |
2.74 |
% |
|
| KZR |
Kezar Life Sciences, Inc. |
CFO |
• – – |
2019-11-13 |
4 |
B |
$2.76 |
$2,207 |
I/I |
800 |
2,000 |
1.91 |
- |
|
| KZR |
Kezar Life Sciences, Inc. |
CFO |
• – – |
2019-08-20 |
4 |
B |
$4.42 |
$884 |
I/I |
200 |
1,200 |
1.91 |
- |
|
| KZR |
Kezar Life Sciences, Inc. |
CFO |
• – – |
2019-08-09 |
4 |
B |
$4.82 |
$2,410 |
I/I |
500 |
1,000 |
1.91 |
- |
|
| KZR |
Kezar Life Sciences, Inc. |
CFO |
• – – |
2019-07-26 |
4 |
B |
$5.80 |
$325 |
I/I |
56 |
500 |
1.91 |
- |
|
| KZR |
Kezar Life Sciences, Inc. |
CFO |
• – – |
2019-07-25 |
4 |
B |
$5.65 |
$2,510 |
I/I |
444 |
444 |
1.91 |
- |
|
| FPRX |
Five Prime Therapeutics I... |
Senior Vice President and CFO |
• – – |
2018-02-05 |
4 |
D |
$18.42 |
$19,304 |
D/D |
(1,048) |
13,314 |
0 |
- |
|
| FPRX |
Five Prime Therapeutics I... |
Senior Vice President and CFO |
• – – |
2017-09-01 |
4 |
D |
$34.34 |
$31,627 |
D/D |
(921) |
16,982 |
0 |
- |
|
| FPRX |
Five Prime Therapeutics I... |
Senior Vice President and CFO |
• – – |
2017-03-01 |
4 |
D |
$44.77 |
$845,302 |
I/I |
(18,881) |
46,785 |
0 |
- |
|
| FPRX |
Five Prime Therapeutics I... |
Senior Vice President and CFO |
• – – |
2017-02-07 |
4 |
A |
$0.00 |
$0 |
D/D |
12,656 |
12,656 |
0 |
- |
|
| FPRX |
Five Prime Therapeutics I... |
Senior Vice President and CFO |
• – – |
2017-01-03 |
4 |
D |
$48.60 |
$110,857 |
I/I |
(2,281) |
65,666 |
0 |
- |
|
| FPRX |
Five Prime Therapeutics I... |
Senior Vice President and CFO |
• – – |
2016-09-01 |
4 |
A |
$44.74 |
$804,425 |
D/D |
17,980 |
67,947 |
0 |
- |
|
| FPRX |
Five Prime Therapeutics I... |
Senior Vice President and CFO |
• – – |
2016-08-25 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
85,927 |
0 |
- |
|
| FPRX |
Five Prime Therapeutics I... |
Senior Vice President and CFO |
• – – |
2016-04-22 |
4 |
AS |
$49.24 |
$1,705,254 |
D/D |
(34,102) |
80,927 |
0 |
- |
|
| FPRX |
Five Prime Therapeutics I... |
Senior Vice President and CFO |
• – – |
2016-04-22 |
4 |
OE |
$5.54 |
$319,373 |
D/D |
34,102 |
115,029 |
0 |
- |
|
| FPRX |
Five Prime Therapeutics I... |
Senior Vice President and CFO |
• – – |
2016-04-06 |
4 |
AS |
$45.04 |
$937,463 |
D/D |
(20,814) |
80,927 |
0 |
- |
|
| FPRX |
Five Prime Therapeutics I... |
Senior Vice President and CFO |
• – – |
2016-04-06 |
4 |
OE |
$4.56 |
$156,713 |
D/D |
20,814 |
101,741 |
0 |
- |
|
| FPRX |
Five Prime Therapeutics I... |
Senior Vice President and CFO |
• – – |
2016-03-30 |
4 |
AS |
$40.01 |
$362,171 |
D/D |
(9,052) |
80,927 |
0 |
- |
|
| FPRX |
Five Prime Therapeutics I... |
Senior Vice President and CFO |
• – – |
2016-03-30 |
4 |
OE |
$4.56 |
$41,277 |
D/D |
9,052 |
89,979 |
0 |
- |
|
| FPRX |
Five Prime Therapeutics I... |
Senior Vice President and CFO |
• – – |
2016-03-29 |
4 |
OE |
$4.56 |
$21,997 |
D/D |
4,824 |
85,751 |
0 |
- |
|
| FPRX |
Five Prime Therapeutics I... |
Senior Vice President and CFO |
• – – |
2016-03-29 |
4 |
AS |
$40.00 |
$192,960 |
D/D |
(4,824) |
80,927 |
0 |
- |
|
| FPRX |
Five Prime Therapeutics I... |
SVP and CFO |
• – – |
2015-08-20 |
4 |
A |
$0.00 |
$0 |
D/D |
75,000 |
80,680 |
0 |
- |
|
| FPRX |
Five Prime Therapeutics I... |
SVP and CFO |
• – – |
2015-04-30 |
4 |
A |
$0.00 |
$0 |
D/D |
5,680 |
5,680 |
0 |
- |
|
23 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
